Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Abstract Background BAT1706 is a proposed biosimilar of bevacizumab, a vascular endothelial growth factor A (VEGF-A)-targeting biologic used to treat several different cancers, including metastatic colorectal cancer. A comprehensive physicochemical and functional similarity assessment is a key compo...

Full description

Bibliographic Details
Main Authors: Di Cao, Chunping Deng, Guangying Wang, Xiong Mei, Jianhua Xie, Yuanmei Liu, Yujie Liu, Yili Yang, Shengfeng Li, Cuihua Liu
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-07-01
Series:Drugs in R&D
Online Access:https://doi.org/10.1007/s40268-023-00432-8

Internet

https://doi.org/10.1007/s40268-023-00432-8

Similar Items